SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-17-005867
Filing Date
2017-02-01
Accepted
2017-02-01 17:29:17
Documents
6
Period of Report
2016-11-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a17-3593_18ka.htm 8-K/A 32782
2 EX-23.1 a17-3593_1ex23d1.htm EX-23.1 4183
3 EX-99.1 a17-3593_1ex99d1.htm EX-99.1 331421
4 EX-99.2 a17-3593_1ex99d2.htm EX-99.2 378211
5 GRAPHIC g35931mm05i001.jpg GRAPHIC 2176
6 GRAPHIC g35931mm01i001.jpg GRAPHIC 3059
  Complete submission text file 0001104659-17-005867.txt   755269
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36306 | Film No.: 17565952
SIC: 2834 Pharmaceutical Preparations